Literature DB >> 35237995

Localization of Long Noncoding RNA in Formalin-Fixed, Paraffin-Embedded Vascular Tissue Using In Situ Hybridization.

Jessica P Scanlon1, Andrew H Baker1,2, Judith C Sluimer3,4.   

Abstract

In situ hybridization (ISH) is a technique for the detection of the location of RNA within a tissue of interest. This process uses oligonucleotides with complementary sequences to bind to the target RNA, and colorimetric detection to allow for the visualization of this binding. The process of ISH means that the specific location of the RNA in question can be detected, including in which cell types it is present, and the intracellular location. In the case of long noncoding RNA (lncRNA), which do not lead to the production of proteins, ISH is essential for tissue localization. Moreover, RNA abundance is often lower than for protein-coding genes, thus necessitating enhanced detection through double-digoxigenin (DIG) labeling of the probes. Here, we describe the theory and practicalities of performing ISH for lncRNA, with particular reference to vascular tissues.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  In situ hybridization; Localization; Long noncoding RNA; Vascular

Mesh:

Substances:

Year:  2022        PMID: 35237995     DOI: 10.1007/978-1-0716-1924-7_41

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  12 in total

Review 1.  Non-coding RNAs in human disease.

Authors:  Manel Esteller
Journal:  Nat Rev Genet       Date:  2011-11-18       Impact factor: 53.242

2.  Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction.

Authors:  Nobuaki Ishii; Kouichi Ozaki; Hiroshi Sato; Hiroya Mizuno; Atsushi Takahashi; Yoshinari Miyamoto; Shiro Ikegawa; Naoyuki Kamatani; Masatsugu Hori; Yusuke Nakamura; Toshihiro Tanaka
Journal:  J Hum Genet       Date:  2006-10-26       Impact factor: 3.172

Review 3.  Long noncoding RNAs in cardiovascular diseases.

Authors:  Shizuka Uchida; Stefanie Dimmeler
Journal:  Circ Res       Date:  2015-02-13       Impact factor: 17.367

4.  Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes.

Authors:  Stine Jørgensen; Adam Baker; Søren Møller; Boye Schnack Nielsen
Journal:  Methods       Date:  2010-07-16       Impact factor: 3.608

5.  Molecular hybridization of radioactive DNA to the DNA of cytological preparations.

Authors:  M L Pardue; J G Gall
Journal:  Proc Natl Acad Sci U S A       Date:  1969-10       Impact factor: 11.205

6.  ANRIL expression is associated with atherosclerosis risk at chromosome 9p21.

Authors:  Lesca M Holdt; Frank Beutner; Markus Scholz; Stephan Gielen; Gábor Gäbel; Hendrik Bergert; Gerhard Schuler; Joachim Thiery; Daniel Teupser
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-01-07       Impact factor: 8.311

7.  Long noncoding RNAs in patients with acute myocardial infarction.

Authors:  Mélanie Vausort; Daniel R Wagner; Yvan Devaux
Journal:  Circ Res       Date:  2014-07-17       Impact factor: 17.367

Review 8.  Targeting Non-coding RNA in Vascular Biology and Disease.

Authors:  John Hung; Vladislav Miscianinov; Judith C Sluimer; David E Newby; Andrew H Baker
Journal:  Front Physiol       Date:  2018-11-22       Impact factor: 4.566

9.  Identification of candidate long non-coding RNAs in response to myocardial infarction.

Authors:  Jennifer Zangrando; Lu Zhang; Melanie Vausort; Fatiha Maskali; Pierre-Yves Marie; Daniel R Wagner; Yvan Devaux
Journal:  BMC Genomics       Date:  2014-06-10       Impact factor: 3.969

10.  Novel Plaque Enriched Long Noncoding RNA in Atherosclerotic Macrophage Regulation (PELATON).

Authors:  John Hung; Jessica P Scanlon; Amira D Mahmoud; Julie Rodor; Margaret Ballantyne; Margaux A C Fontaine; Lieve Temmerman; Jakub Kaczynski; Katie L Connor; Raghu Bhushan; Erik A L Biessen; David E Newby; Judith C Sluimer; Andrew H Baker
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-12-12       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.